Diabetech - Diabetes Tech, Research, News

We dive into the growing off-label use of GLP-1 medications like Ozempic, Wegovy, and Mounjaro among people with type 1 diabetes. I'm joined by longtime diabetes advocate and healthcare executive Marie Schiller to explore the benefits, risks, and evolving research around these drugs. We discuss new studies, including the ADJUST-T1D trial, showing improved A1C, increased time in range, reduced insulin needs, and moderate weight loss—without major safety concerns. Marie shares her personal journey with GLP-1s, why they could be a game-changer when combined with AID systems, and the barriers to insurance coverage and FDA approval. The conversation also covers how people are accessing these medications, ongoing clinical trials, and the need for a multipronged treatment approach in type 1 care.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

AI-powered food tracking is changing how people with diabetes count carbs and manage their glucose. In this episode, I speak with Aurelian Briner, CEO and co-founder of the SNAQ app—an AI-driven diabetes app that uses photos, voice notes, and machine learning to estimate carbs, log meals, and predict glucose spikes. We dive into how AI is transforming diabetes management, the importance of personalized insights, and the challenges of building accurate food recognition tools. With new features like Dexcom’s Smart Food Log and the growing potential of AI companions, this episode explores what the future of diabetes tech looks like.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Brandon Arbiter, Co-founder and acting CEO of Tidepool, is a type 1 diabetes advocate and innovator. He dives into the early days of diabetes data integration and the rise of DIY automated insulin delivery (AID) systems. Brandon shares his journey from misdiagnosis to developing Tidepool, which played a crucial role in FDA-clearing the Loop algorithm. He discusses the importance of community involvement, the future of proactive diabetes care with personalized algorithms, and his advice for aspiring builders in diabetes tech.

Dexcom addresses growing concerns over G7 sensor failures, the recall of receivers with faulty alerts, and an FDA warning letter. We also discuss the upcoming 15-day Dexcom G7, AI food tracking and a new integration between Stelo and Oura Ring. Drop your questions and comments on YouTube.   Join our Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

In this episode, Justin speaks with Melissa Holloway, the founder of SmartStart and a type 1 for over 30 years, opens up about her personal fight to access an insulin pump after moving to the UK—and how that journey led her to become a force for change in the diabetes community. Together, they explore how one voice can make a difference and why community-driven events like Friends for Life are so essential for families navigating type 1. Whether you're a parent, caregiver, or person living with T1D, this is a story of advocacy, resilience, and impact you won’t want to miss.   Join our Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

We break down the biggest diabetes tech and research highlights from the 2025 ADA Scientific Sessions. Justin is joined by CDCES Gary Scheiner to discuss new tubeless insulin pumps, an implantable continuous glucose monitor, and updates on a dual glucose-ketone sensor. We also explore cutting-edge research on islet cell therapies, ultra-concentrated insulins, and the potential of amylin as a complementary hormone treatment.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

In this live episode of Diabetech, I'm joined by Jen Greaves in Valencia, Spain! Jen is a fellow T1D, world traveler, and content creator who spent four months exploring Latin America—all while managing life with type 1. We talk about what it takes to travel long-term with T1D, from navigating insulin supply challenges to staying on top of tech and routines while constantly on the move. Now that I’ve been traveling as a digital nomad for ten months myself, I had a ton of questions for her—and this episode is full of helpful insights, laughs, and honest reflections. Whether you're a T1D dreaming of your next adventure or just curious how we make it all work on the road, this one’s for you. Watch our videos on Jen's page with the links below.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Watch: T1D Travel Essentials with Jen Grieves   Watch: Expert Travel Tips from my Diabetes Educator   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Over the last 8 months, I’ve been traveling the world as a digital nomad, and I want everyone with diabetes to know—it is possible to travel safely and confidently. Today I'm joined by my diabetes educator, Mary Rose, who helped guide me through my very first trip with type 1 diabetes! Mary Rose and I cover everything from what to pack and how to prep with your care team, to airport security tips, managing insulin on long flights, and important conversations to have with your travel companions. Whether you’re planning a weekend getaway or a months-long journey, this episode is full of practical advice and encouragement.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter & Read the Blog    My Vacation Packing List | Doctor's Note for Vacation   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

We dive into growing concerns around reliability issues with the Dexcom G7. After posting a video online that sparked nearly 1,000 comments from users reporting sensor failures, it became clear that this wasn’t an isolated problem. To explore what’s going on, I’m joined by two experts in the diabetes space: Kamil of the Nerdabetic YouTube channel, and Dr. David Ahn, a practicing endocrinologist. We discuss the recent FDA warning letter Dexcom received, reports of sensor connectivity failures and applicator issues like “goosenecking,” and whether Dexcom is facing scrutiny simply because of its popularity. Most importantly, we talk about the need for better transparency and communication with users.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Today we explore the evolution of continuous glucose monitors (CGMs) — from the first professional CGM in 1999 to the advanced tech driving today’s AID systems, and how these devices changed patient lives along the way. Dr. Grazia Aleppo, a leading endocrinologist and early CGM believer, joins to discuss early CGM innovations, the challenges of adoption, and pivotal research that expanded global access. Plus, we look ahead to what the future of CGM technology might hold. Have you used any of these CGMs? Let us know what it was like in the comments on Youtube.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.